A nurse is caring for a client with acute lymphoblastic leukemia (ALL) who has just completed the first cycle of chemotherapy. Which assessment finding requires the nurse's immediate attention?

For a client with acute lymphoblastic leukemia (ALL) who has just completed the first cycle of chemotherapy, you are entering the period of profound bone marrow suppression, known as the nadir. During this time, the client is at extreme risk for three major complications: infection secondary to neutropenia, bleeding secondary to thrombocytopenia, and fatigue secondary to anemia. While all the provided laboratory values and symptoms are abnormal and require intervention, your immediate priority must be guided by the potential for rapid clinical deterioration and mortality. In the context of neutropenia, a fever is not just a symptom—it is an oncologic emergency.

The finding that demands immediate attention is a temperature of 101.8°F (38.8°C) with chills. This presentation in a client with a white blood cell count of 1,200/mm³ defines a clinical scenario known as febrile neutropenia (FN). The absolute neutrophil count (ANC), while not directly given, is critically low given the total WBC count, rendering the client unable to mount an effective inflammatory response. The presence of chills (rigors) strongly suggests a bloodstream infection, which can progress to septic shock within hours in an immunocompromised host.

The provided evidence underscores the gravity of this situation. Febrile neutropenia is explicitly identified as "a frequent and potentially life-threatening complication" and "one of the leading causes of treatment-related mortality in children with malignancies" [2,3]. The standard of care is to treat this as a time-sensitive emergency, with a door-to-needle time (DTNT) for antibiotic administration of less than 60 minutes ^[3]. Delays in antibiotic therapy are directly linked to increased mortality. The implementation of specific triage protocols and rapid diagnostic tools, such as the Sepsis qPCR panel, highlights the clinical urgency to identify pathogens and initiate targeted therapy faster than conventional blood cultures allow [2,4].

The other assessment findings are expected complications of chemotherapy-induced myelosuppression and, while serious, do not carry the same immediate, minute-by-minute threat to life as febrile neutropenia.

• White blood cell count of 1,200/mm³: This severe leukopenia is the underlying cause of the client's risk. It is a critical value that necessitates protective isolation, but it is the combination of this neutropenia with fever that creates the emergency. The neutropenia itself is an expected finding during the nadir period, not an acute change requiring the same emergent intervention as a new fever .


• Platelet count of 45,000/mm³: This represents severe thrombocytopenia and places the client at risk for spontaneous bleeding, including intracranial hemorrhage. The nurse would immediately initiate bleeding precautions. However, unless there is active, uncontrolled hemorrhage, this finding is of a lower immediate priority than a suspected systemic infection. The risk of death from septic shock in the next few hours is higher than the risk of death from a spontaneous bleed at this platelet level.


• Hemoglobin level of 8.2 g/dL: This moderate anemia explains the client's likely fatigue and pallor. The body can compensate for this gradual drop in hemoglobin through increased cardiac output and a shift in the oxygen-hemoglobin dissociation curve. This condition requires monitoring and eventual transfusion per protocol, but it does not pose an immediate threat to airway, breathing, or circulation in the way that sepsis does.

In a client with a healthy immune system, a fever triggers a cascade of inflammatory responses that help contain and destroy pathogens. In a client with profound neutropenia, this defense is absent. Bacteria, often from the client's own gastrointestinal or skin flora, can translocate into the bloodstream without resistance. The fever and chills are often the only initial signs of a rapidly multiplying infection because the typical signs of inflammation—pus, swelling, and localized pain—require neutrophils to form. Therefore, a single temperature spike of 101.8°F in this context must be assumed to be a life-threatening bacteremia until proven otherwise. The research on FN burden confirms that the duration of severe neutropenia is a key factor in the development of these episodes, and aggressive supportive care, including nutritional support, is a focus of management to mitigate these risks .

The nurse's immediate action must be to perform a rapid assessment (vital signs, perfusion status), obtain blood cultures (from all lumens of a central line if present and peripherally), and administer the first dose of a broad-spectrum intravenous antibiotic as prescribed, all within the 60-minute target window from fever recognition [3,4]. This sequence of actions directly addresses the most likely and most lethal threat to the client's survival.